OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Nuclear Medicine is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation	57
Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives	54
Imaging of COVID-19: CT, MRI, and PET	47
Application of Deep Learning in Breast Cancer Imaging	47
Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders	43
Imaging of Head and Neck Cancer With CT, MRI, and US	41
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	41
Imaging of Tumor Hypoxia for Radiotherapy: Current Status and Future Directions	40
Ischemic Heart Disease: An Update	40
PET and SPECT Tracers for Myocardial Perfusion Imaging	39
Intelligent Imaging in Nuclear Medicine: the Principles of Artificial Intelligence, Machine Learning and Deep Learning	37
Ethical and Legal Challenges of Artificial Intelligence in Nuclear Medicine	35
[18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications	33
PET/MR in Head and Neck Cancer – An Update	31
Clinical Management of COVID-19 Patients – An Update	31
Radiomics in PET/CT: Current Status and Future AI-Based Evolutions	30
Advances in Brain Amyloid Imaging	30
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors	28
Imaging of Tau Pathology in Neurodegenerative Diseases: An Update	28
Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies	26
FDG-PET/CT of COVID-19 and Other Lung Infections	25
Recent Developments in SPECT/CT	25
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls	25
Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images	23
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	22

Imaging for Response Assessment in Cancer Clinical Trials	22
PET Agents in Dementia: An Overview	22
Application and Translation of Artificial Intelligence to Cardiovascular Imaging in Nuclear Medicine and Noncontrast CT	22
Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer	21
Sentinel Lymph Node Methods in Breast Cancer	21
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers	21
A role of FDG-PET/CT for response evaluation in metastatic breast cancer?	20
15O-Water PET MPI: Current Status and Future Perspectives	19
16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer	19
Clinical Use of PET/MR in Oncology: An Update	18
Social Asymmetry, Artificial Intelligence and the Medical Imaging Landscape	17
How to Design AI-Driven Clinical Trials in Nuclear Medicine	17
PET/CT Variants and Pitfalls in Gynecological Cancers	17
The Future of Cardiac Molecular Imaging	17
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget	17
The Role of 18-F FDG PET/CT in Imaging of Endocarditis and Cardiac Device Infections	16
FAPI-avid nonmalignant PET/CT findings: An expedited systematic review	16
PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer	16
Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT	16
Imaging for Target Delineation in Head and Neck Cancer Radiotherapy	16
PET Perfusion and Flow Assessment: Tomorrows’ Technology Today	15
Hyperpolarized MRI – An Update and Future Perspectives	15
Radiation Dosimetry in 177Lu-PSMA-617 Therapy	15
Digital PET vs Analog PET: Clinical Implications?	14
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls	14
PET/CT in Bladder Cancer: An Update	14
Total-body PET/CT – First Clinical Experiences and Future Perspectives	14
Measurement of Glomerular Filtration Rate	14
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma	14
Radiation Safety and Accidental Radiation Exposures in Nuclear Medicine	13
Hybrid Imaging of Vascular Cognitive Impairment	13
PET/CT in Non-Hodgkin Lymphoma: An Update	13
Artificial Intelligence for Response Evaluation With PET/CT	12
A Role for FDG PET Radiomics in Personalized Medicine?	12
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy	12
PET/CT Variants and Pitfalls in Breast Cancers	12
Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections	12
Cardiac PET/MRI: Current Clinical Status and Future Perspectives	12
Radiation Dose Modulation of Computed Tomography Component in Positron Emission Tomography/Computed Tomography	11
Advances in PET/CT Technology: An Update	11
The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer	11
Cardiac Imaging With 123I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives	11
Role of Non-FDG-PET/CT in Head and Neck Cancer	11
Variants and Pitfalls of PET/CT in Neuroendocrine Tumors	11
Mediastinal Masses: 18F-FDG-PET/CT Features Based on the International Thymic Malignancy Interest Group Classification	11
Advancement in Production of Radiotracers	11
PET/CT in Surgical Planning for Head and Neck Cancer	11
Pitfalls on PET/MRI	11
PET/MR Technology: Advancement and Challenges	11
A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques?	11